Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-10-01, Stock:JNJ, The news for the past five days is as follows:
2020-09-24: NEWS1: All the Covid-19 Vaccine Candidates That Are Now in Final Trials.NEWS2: Novavax Starts a Phase 3 Trial of Its Covid-19 Vaccine.NEWS3: Johnson & Johnson stock rises Thursday, still underperforms market.NEWS4: Moderna Stock Can’t Go Much Higher—Even If It Makes a Covid-19 Vaccine.NEWS5: FDA flags health risks from 'Benadryl Challenge'.NEWS6: Coronavirus update: Trump suggests he may overrule FDA vaccine approval; airlines ramp up testing.NEWS7: Morning Bell With Jim Cramer: Is Johnson & Johnson a Buy?.NEWS8: Current Updates On COVID-19 Vaccine.NEWS9: U.S. appeals court rejects novel opioid settlement framework.NEWS10: Moderna May Be Too Lofty, Even If It Makes a Covid-19 Vaccine, Analyst Says.NEWS11: Moderna May Be Too Lofty, Even If It Makes a Covid-19 Vaccine, Analyst Says.NEWS12: With Q3 Earnings Up Ahead, Can Johnson & Johnson Set the Table?.NEWS13: Dow Jones Today, Stocks Rebound Off Opening Lows; Tesla Drags On Nasdaq; Jefferies Financial, Owens & Minor Spike.NEWS14: Dow Jones Today, Futures Turn Lower As Tesla Drags On Nasdaq; Jefferies Financial, Owens & Minor Spike.NEWS15: The Stock Market Is Having a September to Forget.NEWS16: 3 Stocks to Buy Ahead of the Next Market Crash.NEWS17: A List of All the Covid-19 Vaccine Candidates That Are Now in Final Trials.NEWS18: Top 3 Dividend Stocks You'll Want to Own Forever.NEWS19: For Investors, Is Owning Johnson & Johnson Stock a Vice or a Virtue?.NEWS20: Johnson & Johnson Begins Final Stage Trial of COVID-19 Vaccine; Target Price $170.NEWS21: PRESS DIGEST- New York Times business news - Sept 24.NEWS22: Trump Says Kentucky Attorney General Is Handling Breonna Taylor Situation ‘Very Well’.NEWS23: Trump says Kentucky attorney general is ‘handling’ Breonna Taylor situation ‘very well’ and refuses to commit to peaceful transition of power.
2020-09-25: NEWS1: Chesapeake Utilities to Join S&P SmallCap 600.NEWS2: Dow Jones Finishes Week With Strong Gains; This Leaderboard Stock Is In Buy Range.NEWS3: Johnson & Johnson stock rises Friday, still underperforms market.NEWS4: Analyst Report: Johnson & Johnson.NEWS5: Johnson & Johnson COVID-19 vaccine produces strong immune response in early trial.NEWS6: There are four coronavirus vaccines in late-stage studies — here’s how they differ.NEWS7: Why Covid-19 Vaccine Prices May Be Unexpectedly Low.NEWS8: Dow Jones Up 100 Points After Early Dive; Apple, Microsoft Lead Tech Stock Rally.NEWS9: J&J: most Phase 1/2a participants in COVID-19 vaccine developed neutralizing antibodies.NEWS10: Dow Jones Comes Back From Early Dive; Apple, Microsoft Lead Tech Stock Rally.NEWS11: U.S. nears 7M coronavirus cases, big pharmaceutical companies race for a vaccine.NEWS12: J&J signs manufacturing deal with GRAM for potential COVID-19 vaccine.NEWS13: Is JNJ Stock A Buy As Pharma Giant Starts Final-Phase Coronavirus Vaccine Trials?.NEWS14: Another Covid-19 Vaccine Candidate Is in the Final Stage of Testing.NEWS15: Novavax Is Starting a Phase 3 Trial of Its Covid-19 Vaccine. The Stock Is Jumping..NEWS16: 3 Dividend Aristocrats to Buy and Hold Forever.NEWS17: Patient Investors Will Stick With Very Cheap Bristol-Myers Squibb Stock.
2020-09-28: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: Biotech ETFs in Focus as the COVID-19 Vaccine Race Intensifies.NEWS3: Johnson & Johnson stock rises Monday, still underperforms market.NEWS4: Inovio Forced To Delay Planned Testing Of Covid-19 Vaccine; Stock Plummets.NEWS5: Official COVID-19 death toll probably underestimates true total - WHO.NEWS6: Dow Jones Vaults 500 Points To Retake Key Support In Broad Stock Market Rally.NEWS7: My Ratings on the Largest 20 Stocks.
2020-09-29: NEWS1: Johnson & Johnson stock outperforms competitors despite losses on the day.NEWS2: Jabil Inc. -- Moody's announces completion of a periodic review of ratings of Jabil Inc..
2020-09-30: nan

Answer: Decrease